[
  {
    "patient_ID": "TCGA.CS.4941",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing": false,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.4942",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1241,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1260,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 800,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4800
  },
  {
    "patient_ID": "TCGA.CS.4943",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 408,
    "pharmaceutical_tx_ongoing": true,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.5390",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 886,
    "drug_units": "MG",
    "drug_dose": 300,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.5393",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing": false,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.5395",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 411,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 579,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 980,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10780
  },
  {
    "patient_ID": "TCGA.CS.5395",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 259,
    "pharmaceutical_tx_ongoing": false,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.5396",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing": true,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 360,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.5397",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing": false,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.6186",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 188,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.6186",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 444,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 512,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 840,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 6720
  },
  {
    "patient_ID": "TCGA.CS.6188",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 716,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.6290",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 504,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.6665",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing": true,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 250,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.6666",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing": true,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.6668",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing": true,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.6669",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing": true,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.6670",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 201,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.CS.6670",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": -325,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": -227,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 1000,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 5000
  },
  {
    "patient_ID": "TCGA.CS.6670",
    "drug_therapy_name": "VINBLASTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": -49,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": -30,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 2,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 4
  },
  {
    "patient_ID": "TCGA.DB.5270",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 761,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 917,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1080
  },
  {
    "patient_ID": "TCGA.DB.5273",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 302,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12450
  },
  {
    "patient_ID": "TCGA.DB.5273",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 74,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6720
  },
  {
    "patient_ID": "TCGA.DB.5274",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 270,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10800
  },
  {
    "patient_ID": "TCGA.DB.5274",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 98,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5670
  },
  {
    "patient_ID": "TCGA.DB.5275",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 129,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6300
  },
  {
    "patient_ID": "TCGA.DB.5275",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 359,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 14000
  },
  {
    "patient_ID": "TCGA.DB.5276",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 283,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9000
  },
  {
    "patient_ID": "TCGA.DB.5276",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 69,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6510
  },
  {
    "patient_ID": "TCGA.DB.5276",
    "drug_therapy_name": "IMATINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1196,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1342,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_dose": 300,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DB.5276",
    "drug_therapy_name": "IMATINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1011,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1189,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 600,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DB.5277",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 61,
    "drug_cycles": 5,
    "drug_units": "MG/M2/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5250
  },
  {
    "patient_ID": "TCGA.DB.5277",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 361,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9900
  },
  {
    "patient_ID": "TCGA.DB.5277",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1117,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1239,
    "drug_units": "MG",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DB.5281",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 276,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12000
  },
  {
    "patient_ID": "TCGA.DB.5281",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 95,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6300
  },
  {
    "patient_ID": "TCGA.DB.A4XB",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 57,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DB.A4XD",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 291,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DB.A4XF",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 264,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DB.A4XG",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1732,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2067,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DB.A64O",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 461,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 551,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DB.A64P",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 430,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DB.A64Q",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DB.A64V",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 330,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DB.A64W",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 274,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DB.A64X",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 265,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DB.A75K",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 64,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DB.A75L",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DB.A75M",
    "drug_therapy_name": "CDR0000654697",
    "pharmaceutical_therapy_type": "PHASE I TRIAL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DH.5140",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 98,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_total_dose_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3375
  },
  {
    "patient_ID": "TCGA.DH.5140",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 342,
    "drug_cycles": 2,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DH.5140",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 250,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_total_dose_units": "MG/KG",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1000
  },
  {
    "patient_ID": "TCGA.DH.5140",
    "drug_therapy_name": "AT-101",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 385,
    "pharmaceutical_tx_ongoing": false,
    "drug_cycles": 2,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DH.5141",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 890,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 936,
    "drug_cycles": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DH.5141",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DH.5142",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 93,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 360,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "patient_ID": "TCGA.DH.5142",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 400,
    "drug_cycles": 11,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 480,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5280
  },
  {
    "patient_ID": "TCGA.DH.5142",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 52,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_total_dose_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2400
  },
  {
    "patient_ID": "TCGA.DH.5143",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 64,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_total_dose_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3000
  },
  {
    "patient_ID": "TCGA.DH.5143",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 99,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1500
  },
  {
    "patient_ID": "TCGA.DH.5143",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing": true,
    "drug_cycles": 12,
    "drug_units": "MG/M2/DAY",
    "drug_total_dose_units": "MG/M2",
    "drug_dose": 200,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DH.A66B",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 432,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DH.A66D",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 73,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DH.A66G",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 211,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DH.A7UR",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1076,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DH.A7UT",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 97,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DH.A7UU",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 88,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DH.A7UV",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 463,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.5847",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 89,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.5847",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 265,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.5847",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 265,
    "drug_cycles": 6,
    "drug_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.5849",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 226,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.5851",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 599,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "patient_ID": "TCGA.DU.5851",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 66,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "patient_ID": "TCGA.DU.5852",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 52,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.5853",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 65,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 165
  },
  {
    "patient_ID": "TCGA.DU.5854",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 90,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "patient_ID": "TCGA.DU.5854",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 134,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 193,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "patient_ID": "TCGA.DU.5854",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 292,
    "pharmaceutical_tx_ongoing": true,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 850
  },
  {
    "patient_ID": "TCGA.DU.5855",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing": true,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 270
  },
  {
    "patient_ID": "TCGA.DU.5855",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 70,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "patient_ID": "TCGA.DU.5870",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 4500,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4543,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.5870",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 4536,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4901,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 230
  },
  {
    "patient_ID": "TCGA.DU.5871",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 57,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "patient_ID": "TCGA.DU.5871",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 222,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 450
  },
  {
    "patient_ID": "TCGA.DU.5872",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 73,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 155
  },
  {
    "patient_ID": "TCGA.DU.5872",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 328,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 370,
    "drug_cycles": 2,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 959
  },
  {
    "patient_ID": "TCGA.DU.5872",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 540,
    "pharmaceutical_tx_ongoing": true,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "patient_ID": "TCGA.DU.5872",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 267,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 310
  },
  {
    "patient_ID": "TCGA.DU.5874",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG/M2",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "patient_ID": "TCGA.DU.6392",
    "drug_therapy_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 78,
    "drug_cycles": 1,
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "patient_ID": "TCGA.DU.6392",
    "drug_therapy_name": "LOMUSTINE;PROCARBAZINE;VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 443,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.6393",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 431,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.6394",
    "drug_therapy_name": "LOMUSTINE;PROCARBAZINE;VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 278,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.6394",
    "drug_therapy_name": "LOMUSTINE;PROCARBAZINE;VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 459,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 459,
    "drug_cycles": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.6394",
    "drug_therapy_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing": false,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG/DAY",
    "drug_dose": 500,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "patient_ID": "TCGA.DU.6395",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1425,
    "pharmaceutical_tx_ongoing": false,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "patient_ID": "TCGA.DU.6395",
    "drug_therapy_name": "LOMUSTINE;PROCARBAZINE;VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1266,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1386,
    "drug_cycles": 4,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.6395",
    "drug_therapy_name": "LOMUSTINE;PROCARBAZINE;VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 870,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1266,
    "drug_cycles": 1,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.6396",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 2127,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2250,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 160
  },
  {
    "patient_ID": "TCGA.DU.6396",
    "drug_therapy_name": "CAPECITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2250,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2250,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "regimen_number": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3500
  },
  {
    "patient_ID": "TCGA.DU.6396",
    "drug_therapy_name": "LOMUSTINE;PROCARBAZINE;VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 89,
    "drug_cycles": 1,
    "regimen_number": 2,
    "drug_route": "ORAL;INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.6396",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1762,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2188,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 225
  },
  {
    "patient_ID": "TCGA.DU.6396",
    "drug_therapy_name": "9-AMINOCAMPTOTHECIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 240,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 636,
    "drug_cycles": 18,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG/M2",
    "drug_dose": 1611,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1611
  },
  {
    "patient_ID": "TCGA.DU.6396",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 915,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1062,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 125,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.6396",
    "drug_therapy_name": "BROMODEOXYURIDINE",
    "pharmaceutical_therapy_type.1": "OTHER",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 59,
    "drug_cycles": 1,
    "pharma_type_other": "RADIOSENSITIZER",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.6396",
    "drug_therapy_name": "ISOTRETINOIN",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1823,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1946,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.6397",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 884,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1219,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 325
  },
  {
    "patient_ID": "TCGA.DU.6401",
    "drug_therapy_name": "SORAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2512,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2512,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 400
  },
  {
    "patient_ID": "TCGA.DU.6401",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2542,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2542,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.6401",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1903,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2451,
    "drug_cycles": 16,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.6402",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 122,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "patient_ID": "TCGA.DU.6403",
    "drug_therapy_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 74,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.6403",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 196,
    "drug_cycles": 2,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.6403",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 10,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.6404",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1762,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1967,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 325,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 600
  },
  {
    "patient_ID": "TCGA.DU.6404",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3227,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3884,
    "drug_cycles": 10,
    "drug_units": "AUC",
    "drug_total_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 870
  },
  {
    "patient_ID": "TCGA.DU.6404",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2360,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2714,
    "drug_cycles": 12,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 134
  },
  {
    "patient_ID": "TCGA.DU.6404",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3154,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3185,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 140
  },
  {
    "patient_ID": "TCGA.DU.6404",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2731,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3060,
    "drug_cycles": 26,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 745
  },
  {
    "patient_ID": "TCGA.DU.6404",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2360,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2714,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 231
  },
  {
    "patient_ID": "TCGA.DU.6404",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 3154,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3185,
    "drug_cycles": 2,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 745
  },
  {
    "patient_ID": "TCGA.DU.6404",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 3227,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3581,
    "drug_cycles": 14,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "drug_dose": 15,
    "regimen_number": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1172
  },
  {
    "patient_ID": "TCGA.DU.6404",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 506,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 385
  },
  {
    "patient_ID": "TCGA.DU.6404",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1602,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1632,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 370
  },
  {
    "patient_ID": "TCGA.DU.6404",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 4066,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4066,
    "drug_cycles": 1,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 635
  },
  {
    "patient_ID": "TCGA.DU.6405",
    "drug_therapy_name": "BORTEZOMIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 530,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 561,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 1.25,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 203
  },
  {
    "patient_ID": "TCGA.DU.6405",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 77,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "patient_ID": "TCGA.DU.6405",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 165,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 499,
    "drug_cycles": 11,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "patient_ID": "TCGA.DU.6405",
    "drug_therapy_name": "CILENGITIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 561,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 561,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1086
  },
  {
    "patient_ID": "TCGA.DU.6406",
    "drug_therapy_name": "ISOTRETINOIN",
    "pharmaceutical_therapy_type.1": "OTHER",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 280,
    "drug_cycles": 5,
    "pharma_type_other": "RETINOID",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.6406",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 66,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.6406",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 280,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG/M2",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.6407",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2473,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2516,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 140
  },
  {
    "patient_ID": "TCGA.DU.6407",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2531,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2774,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 280
  },
  {
    "patient_ID": "TCGA.DU.6407",
    "drug_therapy_name": "AFATINIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2836,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2853,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "patient_ID": "TCGA.DU.6407",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2835,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2853,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 135
  },
  {
    "patient_ID": "TCGA.DU.6408",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1175,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1226,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.6408",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2608,
    "pharmaceutical_tx_ongoing": false,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.6408",
    "drug_therapy_name": "CELECOXIB",
    "pharmaceutical_therapy_type.1": "OTHER",
    "days_to_drug_start": 2608,
    "pharmaceutical_tx_ongoing": false,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.6408",
    "drug_therapy_name": "CAPECITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2608,
    "pharmaceutical_tx_ongoing": false,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.6410",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing": true,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "patient_ID": "TCGA.DU.6542",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 95,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 145
  },
  {
    "patient_ID": "TCGA.DU.6542",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing": true,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "patient_ID": "TCGA.DU.7006",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing": false,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "patient_ID": "TCGA.DU.7006",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing": false,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2
  },
  {
    "patient_ID": "TCGA.DU.7006",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing": false,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "patient_ID": "TCGA.DU.7008",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 239,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 104,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.7008",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 239,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.7008",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 239,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.7009",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3095,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3279,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.7010",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 162,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.7010",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 70,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.7013",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 163,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.DU.7015",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 616,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 884,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 440
  },
  {
    "patient_ID": "TCGA.DU.7015",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 930,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1460,
    "drug_cycles": 17,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.7015",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 930,
    "pharmaceutical_tx_ongoing": true,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.7018",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 635,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 697,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "patient_ID": "TCGA.DU.7018",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 605,
    "drug_cycles": 17,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 330
  },
  {
    "patient_ID": "TCGA.DU.7019",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 71,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "patient_ID": "TCGA.DU.7019",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 436,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 320
  },
  {
    "patient_ID": "TCGA.DU.7292",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 176,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 206,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "patient_ID": "TCGA.DU.7292",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 176,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 206,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "patient_ID": "TCGA.DU.7298",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 207,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 207,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 350
  },
  {
    "patient_ID": "TCGA.DU.7298",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 101,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "patient_ID": "TCGA.DU.7299",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 70,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "patient_ID": "TCGA.DU.7299",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 945,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1157,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 140
  },
  {
    "patient_ID": "TCGA.DU.7299",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 721,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 945,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 256
  },
  {
    "patient_ID": "TCGA.DU.7299",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 721,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1016,
    "drug_cycles": 6,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 911
  },
  {
    "patient_ID": "TCGA.DU.7299",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 456,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 420
  },
  {
    "patient_ID": "TCGA.DU.7300",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 764,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.7300",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1086,
    "pharmaceutical_tx_ongoing": false,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.7300",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1086,
    "pharmaceutical_tx_ongoing": false,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.7300",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 307,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "patient_ID": "TCGA.DU.7300",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 337,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 368,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.DU.7301",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 369,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 450
  },
  {
    "patient_ID": "TCGA.DU.7301",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 379,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 534,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 280
  },
  {
    "patient_ID": "TCGA.DU.7301",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 379,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 629,
    "drug_cycles": 7,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1058
  },
  {
    "patient_ID": "TCGA.DU.7301",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 66,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "patient_ID": "TCGA.DU.7301",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 626,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 643,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 160
  },
  {
    "patient_ID": "TCGA.DU.7302",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1691,
    "pharmaceutical_tx_ongoing": true,
    "drug_cycles": 7,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1020
  },
  {
    "patient_ID": "TCGA.DU.7302",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 530,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 390
  },
  {
    "patient_ID": "TCGA.DU.7302",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1382,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1686,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 155
  },
  {
    "patient_ID": "TCGA.DU.7304",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 318,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "patient_ID": "TCGA.DU.7304",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 363,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 539,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 241
  },
  {
    "patient_ID": "TCGA.DU.7304",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 363,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 623,
    "drug_cycles": 10,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 759
  },
  {
    "patient_ID": "TCGA.DU.7304",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 69,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "patient_ID": "TCGA.DU.7306",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 59,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "patient_ID": "TCGA.DU.7306",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 250,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 310
  },
  {
    "patient_ID": "TCGA.DU.7306",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1283,
    "pharmaceutical_tx_ongoing": true,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 165
  },
  {
    "patient_ID": "TCGA.DU.7309",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 84,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "patient_ID": "TCGA.DU.8158",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 66,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8161",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 78,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8161",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8161",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 134,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 575,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8161",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 638,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8162",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 70,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DU.8162",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8163",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 81,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8163",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8163",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 525,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8164",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8165",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 71,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8165",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8166",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 143,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8166",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 237,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 433,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8166",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 237,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 433,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8168",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 71,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.8168",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A5TP",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A5TP",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 493,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A5TR",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A5TS",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 415,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A5TT",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A5TU",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 627,
    "pharmaceutical_tx_ongoing": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A5TY",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 64,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A5TY",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A5TY",
    "drug_therapy_name": "MIBEFRADIL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 553,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 812,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DU.A5TY",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 553,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 812,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DU.A5TY",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 814,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 855,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A5TY",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 814,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 855,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A5TY",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 872,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 914,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A6S6",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 272,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A6S6",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2283,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A6S6",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2281,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2492,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A6S7",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 57,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A6S7",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A6S7",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 464,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A6S8",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A76K",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 236,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 269,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A76L",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 57,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A76L",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 406,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A76L",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 588,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 617,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DU.A76L",
    "drug_therapy_name": "CILENGITIDE",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 651,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 732,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DU.A76O",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 94,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A76O",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 115,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A76R",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 389,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 394,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7T8",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 193,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7T8",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 211,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 407,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7T8",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3061,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3215,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7T8",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3865,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3901,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7T8",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 4001,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4194,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7T8",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 4001,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4194,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7TA",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 70,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7TA",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 413,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7TB",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 57,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7TB",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 127,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7TB",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 518,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7TD",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 63,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7TD",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7TG",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 128,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7TI",
    "drug_therapy_name": "LEFLUNOMIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 232,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 567,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DU.A7TI",
    "drug_therapy_name": "ONYX-015",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 840,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 840,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DU.A7TI",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 932,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1085,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7TI",
    "drug_therapy_name": "CRA",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1115,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1154,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DU.A7TI",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1115,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1154,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.5302",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 1255,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1303,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8400
  },
  {
    "patient_ID": "TCGA.E1.5302",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 154,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7840
  },
  {
    "patient_ID": "TCGA.E1.5302",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 294,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 433,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 14000
  },
  {
    "patient_ID": "TCGA.E1.5302",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 154,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 1.4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "patient_ID": "TCGA.E1.5302",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1434,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1493,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3700
  },
  {
    "patient_ID": "TCGA.E1.5302",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 294,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7840
  },
  {
    "patient_ID": "TCGA.E1.5302",
    "drug_therapy_name": "CELECOXIB",
    "pharmaceutical_therapy_type.1": "OTHER",
    "days_to_drug_start": 1322,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1434,
    "drug_cycles": 3,
    "pharma_type_other": "NSAID",
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100800
  },
  {
    "patient_ID": "TCGA.E1.5302",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 154,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "patient_ID": "TCGA.E1.5302",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1255,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1303,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "patient_ID": "TCGA.E1.5302",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 294,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "patient_ID": "TCGA.E1.5302",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 433,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 643,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 11100
  },
  {
    "patient_ID": "TCGA.E1.5302",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 294,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 1.4,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "patient_ID": "TCGA.E1.5302",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1322,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1434,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 340,
    "regimen_number": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5670
  },
  {
    "patient_ID": "TCGA.E1.5303",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 218,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 582,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 19375
  },
  {
    "patient_ID": "TCGA.E1.5303",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 190,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "patient_ID": "TCGA.E1.5303",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 215,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1120
  },
  {
    "patient_ID": "TCGA.E1.5304",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 249,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 420
  },
  {
    "patient_ID": "TCGA.E1.5304",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 312,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 398,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 440
  },
  {
    "patient_ID": "TCGA.E1.5304",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 125,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1500
  },
  {
    "patient_ID": "TCGA.E1.5304",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 249,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 312,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3950
  },
  {
    "patient_ID": "TCGA.E1.5304",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 995,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1113,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 7700
  },
  {
    "patient_ID": "TCGA.E1.5304",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1167,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1198,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 10,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2100
  },
  {
    "patient_ID": "TCGA.E1.5304",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1128,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1166,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 723
  },
  {
    "patient_ID": "TCGA.E1.5304",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 125,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 160,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2000
  },
  {
    "patient_ID": "TCGA.E1.5305",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2280,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2331,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "drug_total_dose": 220
  },
  {
    "patient_ID": "TCGA.E1.5305",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 593,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 25200
  },
  {
    "patient_ID": "TCGA.E1.5305",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 593,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 18600
  },
  {
    "patient_ID": "TCGA.E1.5305",
    "drug_therapy_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1636,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1825,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 500,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 84000
  },
  {
    "patient_ID": "TCGA.E1.5305",
    "drug_therapy_name": "IMATINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1636,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1825,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 500,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 84000
  },
  {
    "patient_ID": "TCGA.E1.5305",
    "drug_therapy_name": "TOPOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1861,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1994,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 14400
  },
  {
    "patient_ID": "TCGA.E1.5305",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1861,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1994,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 12000
  },
  {
    "patient_ID": "TCGA.E1.5305",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1994,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2093,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 340,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5440
  },
  {
    "patient_ID": "TCGA.E1.5305",
    "drug_therapy_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2128,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2241,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 730,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 81760
  },
  {
    "patient_ID": "TCGA.E1.5305",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2128,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2241,
    "drug_cycles": 4,
    "drug_units": "MG/KG",
    "drug_total_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10192
  },
  {
    "patient_ID": "TCGA.E1.5307",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 229,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 260,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1250
  },
  {
    "patient_ID": "TCGA.E1.5307",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1462,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1599,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4800
  },
  {
    "patient_ID": "TCGA.E1.5307",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 313,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 351,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 180
  },
  {
    "patient_ID": "TCGA.E1.5307",
    "drug_therapy_name": "CELECOXIB",
    "pharmaceutical_therapy_type.1": "OTHER",
    "days_to_drug_start": 560,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1453,
    "drug_cycles": 41,
    "pharma_type_other": "ANTIONGIOGENIC",
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 45920
  },
  {
    "patient_ID": "TCGA.E1.5307",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 466,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 560,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3750
  },
  {
    "patient_ID": "TCGA.E1.5307",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 215,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "patient_ID": "TCGA.E1.5307",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 382,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 466,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 82.5,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 130
  },
  {
    "patient_ID": "TCGA.E1.5307",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1599,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1720,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 9,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6000
  },
  {
    "patient_ID": "TCGA.E1.5307",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 260,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 285,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1675
  },
  {
    "patient_ID": "TCGA.E1.5311",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2615,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2799,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 13200
  },
  {
    "patient_ID": "TCGA.E1.5311",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2925,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3282,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2000
  },
  {
    "patient_ID": "TCGA.E1.5311",
    "drug_therapy_name": "VNP 40101M",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3868,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3996,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2040
  },
  {
    "patient_ID": "TCGA.E1.5311",
    "drug_therapy_name": "BNP 1350",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2825,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2848,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 2.2,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 11
  },
  {
    "patient_ID": "TCGA.E1.5311",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3996,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4084,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6930
  },
  {
    "patient_ID": "TCGA.E1.5311",
    "drug_therapy_name": "CELECOXIB",
    "pharmaceutical_therapy_type.1": "OTHER",
    "days_to_drug_start": 3282,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3868,
    "drug_cycles": 19,
    "pharma_type_other": "NSAID",
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 425600
  },
  {
    "patient_ID": "TCGA.E1.5311",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 3282,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3749,
    "drug_cycles": 15,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 84000
  },
  {
    "patient_ID": "TCGA.E1.5311",
    "drug_therapy_name": "81C6",
    "pharmaceutical_therapy_type.1": "OTHER",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 20,
    "drug_cycles": 1,
    "pharma_type_other": "BRACHYTHERPY",
    "drug_units": "MCI;MCI",
    "drug_total_dose_units": "MCI;MCI",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 40
  },
  {
    "patient_ID": "TCGA.E1.5318",
    "drug_therapy_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1980,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2043,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 9,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5600
  },
  {
    "patient_ID": "TCGA.E1.5318",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1655,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1904,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 540
  },
  {
    "patient_ID": "TCGA.E1.5318",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 824,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1026,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8400
  },
  {
    "patient_ID": "TCGA.E1.5318",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 2211,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2267,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 80,
    "regimen_number": 12,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4480
  },
  {
    "patient_ID": "TCGA.E1.5318",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 781,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 824,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1650
  },
  {
    "patient_ID": "TCGA.E1.5318",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1590,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1652,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 9,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3000
  },
  {
    "patient_ID": "TCGA.E1.5318",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2211,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2267,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 12,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6720
  },
  {
    "patient_ID": "TCGA.E1.5318",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 385,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 781,
    "drug_cycles": 11,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 560,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6507
  },
  {
    "patient_ID": "TCGA.E1.5318",
    "drug_therapy_name": "CELECOXIB",
    "pharmaceutical_therapy_type.1": "OTHER",
    "days_to_drug_start": 1980,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2043,
    "drug_cycles": 2,
    "pharma_type_other": "NSAIDS",
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 9,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 44800
  },
  {
    "patient_ID": "TCGA.E1.5318",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2023,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2127,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 350,
    "regimen_number": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1710
  },
  {
    "patient_ID": "TCGA.E1.5318",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1043,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1231,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_total_dose_units": "WAFER",
    "drug_dose": 8,
    "regimen_number": 4,
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8
  },
  {
    "patient_ID": "TCGA.E1.5318",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1904,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1971,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 82.5,
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "patient_ID": "TCGA.E1.5318",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2127,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2211,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 260,
    "regimen_number": 11,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3400
  },
  {
    "patient_ID": "TCGA.E1.5318",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2268,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2335,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 82.5,
    "regimen_number": 13,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 280
  },
  {
    "patient_ID": "TCGA.E1.5319",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 952,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1385,
    "drug_cycles": 13,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 26650
  },
  {
    "patient_ID": "TCGA.E1.5319",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1826,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1933,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 560,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 94920
  },
  {
    "patient_ID": "TCGA.E1.5319",
    "drug_therapy_name": "CELECOXIB",
    "pharmaceutical_therapy_type.1": "OTHER",
    "days_to_drug_start": 1385,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1511,
    "drug_cycles": 4,
    "pharma_type_other": "ANTIONGIGENIC",
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 800,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 95200
  },
  {
    "patient_ID": "TCGA.E1.5319",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1933,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1993,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 450,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50400
  },
  {
    "patient_ID": "TCGA.E1.5319",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2322,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2364,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 240
  },
  {
    "patient_ID": "TCGA.E1.5319",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2029,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2121,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4000
  },
  {
    "patient_ID": "TCGA.E1.5319",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2433,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2587,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6300
  },
  {
    "patient_ID": "TCGA.E1.5319",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2364,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2433,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 82.5,
    "regimen_number": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 180
  },
  {
    "patient_ID": "TCGA.E1.5319",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2587,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2818,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_total_dose_units": "MG",
    "drug_dose": 25,
    "regimen_number": 9,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6300
  },
  {
    "patient_ID": "TCGA.E1.5322",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1085,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1109,
    "drug_cycles": 7,
    "drug_units": "WAFER",
    "drug_total_dose_units": "WAFER",
    "drug_dose": 8,
    "regimen_number": 1,
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "patient_ID": "TCGA.E1.A7YD",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 285,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YD",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 314,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YE",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 185,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YE",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 378,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 468,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YE",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 237,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 237,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YE",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "days_to_drug_start": 482,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 695,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YE",
    "drug_therapy_name": "CELECOXIB",
    "pharmaceutical_therapy_type.1": "ANCILLARY",
    "days_to_drug_start": 469,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 703,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YE",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 704,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 731,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YE",
    "drug_therapy_name": "O6-BENZYLGUANINE",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 704,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 731,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7YE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 715,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 787,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7YE",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 790,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 845,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YH",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 87,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YH",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 216,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YH",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 222,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 537,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YH",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 706,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 752,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YH",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 775,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 835,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YH",
    "drug_therapy_name": "ERLOTINIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 867,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1223,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7YH",
    "drug_therapy_name": "BEVACIZUMAB",
    "days_to_drug_start": 867,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1223,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7YH",
    "drug_therapy_name": "BEVACIZUMAB",
    "days_to_drug_start": 1224,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1328,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YH",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1345,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1627,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YJ",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 84,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YJ",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 144,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YJ",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 504,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YJ",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 518,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YJ",
    "drug_therapy_name": "MR1-1",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 537,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 541,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7YK",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 68,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YK",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing": false,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YL",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 78,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YL",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 289,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YL",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 263,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YL",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 249,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YL",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 298,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 336,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YL",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 298,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 325,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YM",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 75,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YM",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 137,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YM",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 137,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YM",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YM",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 164,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YM",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 174,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 497,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YM",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 501,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 593,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YM",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 501,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 593,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YN",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 90,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YN",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 124,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 369,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YN",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 429,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 484,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YN",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 429,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 484,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YN",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 491,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 553,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YN",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 506,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 632,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YO",
    "drug_therapy_name": "81C6",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 23,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7YQ",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 346,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 396,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YQ",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 429,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 512,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YQ",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 532,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 559,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YS",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 106,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YS",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 365,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YU",
    "drug_therapy_name": "81C6",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 6,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7YV",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 82,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YV",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 156,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YV",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 195,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 507,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YV",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 507,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 674,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YV",
    "drug_therapy_name": "IMATINIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 507,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 674,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YV",
    "drug_therapy_name": "IMATINIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 678,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 824,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YV",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 846,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 887,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YV",
    "drug_therapy_name": "IMATINIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 832,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 887,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YV",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 888,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 948,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YV",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 888,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 948,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YW",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 711,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 978,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YW",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 999,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1025,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7YW",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 999,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1025,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7YW",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1040,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1095,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YW",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 418,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 608,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YY",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 982,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1351,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7YY",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2378,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2470,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YY",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2465,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2590,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YY",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3501,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4152,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YY",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 4152,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4207,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7YY",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 4289,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4418,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z2",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 213,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z2",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 230,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 270,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z2",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 286,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 328,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z2",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 293,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 334,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z2",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 356,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 383,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z2",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 356,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 369,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z3",
    "drug_therapy_name": "81C6",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1709,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1709,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7Z3",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1911,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1921,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7Z3",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1911,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1921,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7Z3",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1911,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1921,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7Z3",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1995,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2072,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7Z4",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 883,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 883,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z4",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 896,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 952,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z4",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 974,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1100,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z4",
    "drug_therapy_name": "THALIDOMIDE",
    "days_to_drug_start": 1101,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1176,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7Z4",
    "drug_therapy_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1101,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1176,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7Z4",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1182,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1249,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.E1.A7Z4",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1266,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1834,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z4",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 1266,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1834,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z4",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 3545,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3888,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z4",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 4081,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4124,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z4",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 4081,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4137,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z4",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 4138,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4336,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z4",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 4138,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4308,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z6",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 356,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 705,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z6",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 907,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 964,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.E1.A7Z6",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 901,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 966,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.5962",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 79,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6720
  },
  {
    "patient_ID": "TCGA.FG.5962",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 258,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10800
  },
  {
    "patient_ID": "TCGA.FG.5963",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 428,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 471,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5880
  },
  {
    "patient_ID": "TCGA.FG.5963",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 517,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 690,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.5963",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 511,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 727,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.5963",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 699,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 700,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.5965",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 790,
    "pharmaceutical_tx_ongoing": true,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 9500
  },
  {
    "patient_ID": "TCGA.FG.6688",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 159,
    "pharmaceutical_tx_ongoing": true,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5750
  },
  {
    "patient_ID": "TCGA.FG.6688",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 483,
    "pharmaceutical_tx_ongoing": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.6689",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 267,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 424,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.6691",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1135,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.6692",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.7636",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 84,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6300
  },
  {
    "patient_ID": "TCGA.FG.7638",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 78,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 145,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6090
  },
  {
    "patient_ID": "TCGA.FG.7638",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 336,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.7638",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 411,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 595,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.8181",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.8185",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 70,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.8185",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 412,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.8189",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 159,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FG.8189",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 190,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 221,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FG.8191",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 76,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.8191",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 448,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A4MW",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 71,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A4MW",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A4MW",
    "drug_therapy_name": "BEVACIZUMAB",
    "days_to_drug_start": 231,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 379,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A6J3",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 74,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A6J3",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 116,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A70Y",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 515,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 554,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A70Z",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 298,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 328,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A710",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 218,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A711",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 350,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 673,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A711",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 733,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 774,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A711",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1097,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A711",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1155,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1195,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A711",
    "drug_therapy_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1223,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1277,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A711",
    "drug_therapy_name": "IMATINIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1223,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1277,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A711",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1284,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1329,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A711",
    "drug_therapy_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1284,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1329,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A87N",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FG.A87Q",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FN.7833",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.7468",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing": true,
    "drug_cycles": 5,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 280,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1400
  },
  {
    "patient_ID": "TCGA.HT.7469",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 84,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "patient_ID": "TCGA.HT.7469",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 179,
    "drug_cycles": 3,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6000
  },
  {
    "patient_ID": "TCGA.HT.7470",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 94,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7000
  },
  {
    "patient_ID": "TCGA.HT.7475",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 393,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 441,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7840
  },
  {
    "patient_ID": "TCGA.HT.7475",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 162,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 280,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2800
  },
  {
    "patient_ID": "TCGA.HT.7475",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 186,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 218,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 360,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "patient_ID": "TCGA.HT.7476",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 80,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4200
  },
  {
    "patient_ID": "TCGA.HT.7476",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing": true,
    "drug_cycles": 3,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 280,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1400
  },
  {
    "patient_ID": "TCGA.HT.7477",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 428,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.7479",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 200,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 480,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9600
  },
  {
    "patient_ID": "TCGA.HT.7479",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 74,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7350
  },
  {
    "patient_ID": "TCGA.HT.7480",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 476,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 310,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 18600
  },
  {
    "patient_ID": "TCGA.HT.7480",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2189,
    "pharmaceutical_tx_ongoing": true,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 970,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3880
  },
  {
    "patient_ID": "TCGA.HT.7480",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 75,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 155,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7750
  },
  {
    "patient_ID": "TCGA.HT.7482",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 577,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 853,
    "drug_cycles": 10,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 370,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 18500
  },
  {
    "patient_ID": "TCGA.HT.7483",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2861,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3287,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.7601",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 157,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 310,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3100
  },
  {
    "patient_ID": "TCGA.HT.7601",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 92,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 240,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "patient_ID": "TCGA.HT.7601",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 36,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 120,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5040
  },
  {
    "patient_ID": "TCGA.HT.7604",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2509,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.7606",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 64,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5720
  },
  {
    "patient_ID": "TCGA.HT.7606",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 163,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 470,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 330,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 19800
  },
  {
    "patient_ID": "TCGA.HT.7606",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 102,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 260,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1300
  },
  {
    "patient_ID": "TCGA.HT.7609",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 484,
    "drug_cycles": 12,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 280,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 16800
  },
  {
    "patient_ID": "TCGA.HT.7609",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 75,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6860
  },
  {
    "patient_ID": "TCGA.HT.7620",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing": false,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.HT.7620",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 285,
    "regimen_number": 3,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.HT.7620",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 195,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 199,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 250,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1250
  },
  {
    "patient_ID": "TCGA.HT.7620",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 285,
    "regimen_number": 4,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.HT.7677",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing": true,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9000
  },
  {
    "patient_ID": "TCGA.HT.7677",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 73,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6020
  },
  {
    "patient_ID": "TCGA.HT.7686",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 145,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 239,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6000
  },
  {
    "patient_ID": "TCGA.HT.7686",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 73,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6110
  },
  {
    "patient_ID": "TCGA.HT.7688",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 475,
    "drug_cycles": 11,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 22000
  },
  {
    "patient_ID": "TCGA.HT.7688",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 105,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1500
  },
  {
    "patient_ID": "TCGA.HT.7688",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 59,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6300
  },
  {
    "patient_ID": "TCGA.HT.7689",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 94,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_total_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "patient_ID": "TCGA.HT.7689",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 334,
    "drug_cycles": 5,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 260,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6500
  },
  {
    "patient_ID": "TCGA.HT.7693",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 63,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "patient_ID": "TCGA.HT.7693",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 440,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 370,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20350
  },
  {
    "patient_ID": "TCGA.HT.7695",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 110,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4950
  },
  {
    "patient_ID": "TCGA.HT.7855",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 157,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "patient_ID": "TCGA.HT.7855",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 67,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6880
  },
  {
    "patient_ID": "TCGA.HT.7856",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 71,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6240
  },
  {
    "patient_ID": "TCGA.HT.7874",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 87,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4200
  },
  {
    "patient_ID": "TCGA.HT.7874",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 140,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 240,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "patient_ID": "TCGA.HT.7874",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 549,
    "drug_cycles": 11,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 315,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 17325
  },
  {
    "patient_ID": "TCGA.HT.7879",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 78,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_total_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7000
  },
  {
    "patient_ID": "TCGA.HT.7879",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing": true,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_dose": 250,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.HT.7884",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 84,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.HT.7884",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.HT.8011",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 69,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.8011",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 115,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 242,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.8013",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1334,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1742,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.8013",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1610,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1693,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.8113",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 74,
    "treatment_best_response": "PARTIAL RESPONSE"
  },
  {
    "patient_ID": "TCGA.HT.8113",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 159,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 331,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "patient_ID": "TCGA.HT.8114",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 90,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "patient_ID": "TCGA.HT.8564",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 135,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.8564",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 184,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.8564",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.A4DV",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 88,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.A4DV",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 291,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.A5R7",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.A5RA",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 235,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.A5RC",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 98,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.A618",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.A619",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 443,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.A61A",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.A61B",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.A61C",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.A74H",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HT.A74K",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 277,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.7486",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 216,
    "drug_cycles": 6,
    "drug_total_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.HW.7487",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 409,
    "drug_cycles": 12,
    "drug_total_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "POST-OPERATIVE"
  },
  {
    "patient_ID": "TCGA.HW.7487",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 948,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1249,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.7487",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 960,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1295,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.7487",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 960,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1236,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.7487",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1386,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1417,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.7487",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1570,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.7487",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1570,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.7491",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1011,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.8319",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 66,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.8319",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.8319",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1028,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1058,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.8319",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1058,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1150,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.8319",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1089,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1150,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.8320",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 108,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.8320",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.8321",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 321,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.8322",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 433,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.A5KJ",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 16,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.A5KJ",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "days_to_drug_start": 656,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 899,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.A5KK",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 176,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.A5KK",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 207,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.A5KL",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 71,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HW.A5KL",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 648,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IK.7675",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 510
  },
  {
    "patient_ID": "TCGA.IK.7675",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 531,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 552
  },
  {
    "patient_ID": "TCGA.IK.8125",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 99,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.IK.8125",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 265,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KT.A74X",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 83,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.KT.A7W1",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 61,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.P5.A5EX",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 243,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.P5.A5F0",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 287,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.P5.A5F0",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 287,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.P5.A5F0",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 287,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.P5.A5F2",
    "drug_therapy_name": "MUSTOPHORAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 242,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.P5.A5F2",
    "drug_therapy_name": "BEVACIZUMAB",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 242,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.P5.A5F2",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 242,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.P5.A5F4",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 231,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.P5.A5F4",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 231,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.P5.A5F4",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 231,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.P5.A72Z",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 270,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.P5.A733",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 414,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A65R",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 430,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A65V",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 327,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A65V",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 307,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A65V",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 307,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A65X",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 139,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 143,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A65X",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 237,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 365,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A65X",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 237,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 365,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A65X",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 244,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 365,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A65Z",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 215,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A65Z",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 295,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A65Z",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 315,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A6CS",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 423,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A6CS",
    "drug_therapy_name": "FOTEMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 607,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A6CU",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 399,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A6CY",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 267,
    "pharmaceutical_tx_ongoing": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A6X4",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 196,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 342,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A6X8",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 292,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A6XC",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 390,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A6XC",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 466,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A6XC",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 466,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A6XC",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 466,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QH.A870",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 396,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6TS",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1614,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1697,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6TS",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1352,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1603,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6TS",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1704,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1859,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6TV",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 68,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6TW",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 304,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6TX",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 268,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 856,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6TY",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 274,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6U0",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 64,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6U0",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 264,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6U0",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 698,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6U0",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 603,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6U0",
    "drug_therapy_name": "TENIPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 603,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6U1",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 253,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6U8",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2832,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2988,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6U8",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1995,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2200,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6U8",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2720,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2762,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6U8",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2787,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2794,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6WD",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 322,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6WE",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing": false,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6WG",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 382,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 386,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6WM",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 64,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6WM",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 524,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6WN",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 91,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6WN",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 425,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 805,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6WN",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 317,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 321,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6WN",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 679,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 805,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.S9.A6WN",
    "drug_therapy_name": "PEMBROLIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 846,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A6WP",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7IX",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 350,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 413,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7IX",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 437,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 470,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7IX",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 350,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 413,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7IX",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 589,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 640,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7IY",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 383,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7IY",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 383,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7IY",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 383,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7IZ",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 603,
    "pharmaceutical_tx_ongoing": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7IZ",
    "drug_therapy_name": "TENIPOSIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 603,
    "pharmaceutical_tx_ongoing": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7J0",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 91,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7J0",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7J0",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 399,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 443,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7J0",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 490,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 609,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7J0",
    "drug_therapy_name": "IRINOTECAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 546,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 609,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7J2",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7J2",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7J2",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7J3",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 177,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7J3",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 177,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7J3",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 177,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7QW",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 382,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 592,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.S9.A7QX",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7QY",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 372,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7R1",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3801,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3835,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7R4",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 161,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7R7",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 144,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 526,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7R7",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 716,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1095,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7R7",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2720,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2847,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7R8",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 771,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 786,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A7R8",
    "drug_therapy_name": "NIMUSTINE HYDROCHLORIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 803,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 925,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A89V",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 46,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A89V",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 222,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.S9.A89Z",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 308,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.TM.A7C3",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 748,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.TM.A84B",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 188,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 338,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.TM.A84C",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 297,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 459,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.TM.A84J",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.TM.A84J",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 476,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.TM.A84L",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1066,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1185,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.TM.A84M",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 138,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 264,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.TM.A84M",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 138,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 264,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.TM.A84M",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 138,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 264,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.VM.A8C8",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1282,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1431,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.VM.A8CA",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 373,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.VM.A8CE",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 349,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.VM.A8CE",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 925,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 986,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.VM.A8CE",
    "drug_therapy_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 898,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.VM.A8CE",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 918,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.VM.A8CF",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 88,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.VV.A829",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 792,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.VV.A86M",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.VW.A7QS",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 595,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.VW.A8FI",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 78,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.WH.A86K",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 84,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  }
]
